Lundberg Sven Ante
- SEC CIK
- 0001682126
No open-market purchases or sales filed in the past year.
Current role at each company
- QTTB Q32 Bio Inc.Directoras of Jul 21, 2026
- MRUS Merus N.V.President, CEO & PEOas of Dec 12, 2025
- VOR Vor Biopharma Inc.Directoras of May 23, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lundberg Sven Ante as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRUS Merus N.V.
President, CEO & PEO4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2022 (view filing) | Nov 3 | Same day | Lundberg Sven AntePresident, CEO & PFO | PPurchase | +14.7K | $14.38 | +$211.5K | +56.8%40.6K after | |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Lundberg Sven AntePresident, CEO & PFO | PPurchase | +5.83K | $22.92 | +$133.5K | +29.1%25.9K after | From original |
| Aug 22, 2022 (view filing) | Aug 19 | 3 days | Lundberg Sven AntePresident, CEO & PFO | PPurchase | +704 | $22.99 | +$16.2K | +3.6%20.0K after | |
| Jul 13, 2022 (view filing) | Jul 12 | 1 day | Lundberg Sven AntePresident, CEO & PFO | PPurchase | +4.34K | $22.97 | +$99.7K | +28.9%19.3K after |